DOT1L and breast carcinoma: Motif analysis demonstrated that IFN-stimulated response elements (ISREs) were significantly enriched around the H3K4me3 peaks in breast cancer cells treated with a DOT1L inhibitor (Fig. 4B, Supplementary Fig. S8B).